Selegiline: current perspectives on issues related to neuroprotection and mortality
Neurology
.
1996 Dec;47(6 Suppl 3):S210-6.
doi: 10.1212/wnl.47.6_suppl_3.210s.
Author
C W Olanow
1
Affiliation
1
Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA.
PMID:
8959990
DOI:
10.1212/wnl.47.6_suppl_3.210s
No abstract available
Publication types
Review
MeSH terms
Humans
Neuroprotective Agents / therapeutic use*
Parkinson Disease / drug therapy*
Parkinson Disease / mortality
Selegiline / therapeutic use*
Survival Analysis
Substances
Neuroprotective Agents
Selegiline